Guidelines for radioiodine therapy of differentiated thyroid cancer
M Luster, SE Clarke, M Dietlein, M Lassmann… - European journal of …, 2008 - Springer
Introduction The purpose of the present guidelines on the radioiodine therapy (RAIT) of
differentiated thyroid cancer (DTC) formulated by the European Association of Nuclear …
differentiated thyroid cancer (DTC) formulated by the European Association of Nuclear …
Radio-iodine therapy in differentiated thyroid cancer: indications and procedures
C Reiners, M Dietlein, M Luster - Best Practice & Research Clinical …, 2008 - Elsevier
Post-surgical ablative iodine-131 therapy is recommended for all differentiated thyroid
cancer primary tumors> 1cm in diameter. Regarding smaller primary tumors, 131I ablation …
cancer primary tumors> 1cm in diameter. Regarding smaller primary tumors, 131I ablation …
The Role of the PAX8/PPARγ Fusion Oncogene in Thyroid Cancer
KA Placzkowski, HV Reddi, SKG Grebe… - PPAR …, 2008 - Wiley Online Library
Thyroid cancer is uncommon and exhibits relatively low mortality rates. However, a subset of
patients experience inexorable growth, metastatic spread, and mortality. Unfortunately, for …
patients experience inexorable growth, metastatic spread, and mortality. Unfortunately, for …
Radioiodine therapy after pretreatment with bexarotene for metastases of differentiated thyroid carcinoma
YY Liu, MP Stokkel, HA Morreau… - Clinical …, 2008 - Wiley Online Library
Objective To evaluate the effects of pretreatment with the retinoid X receptor (RXR) agonist
bexarotene on the efficacy of radioiodine therapy for metastases of differentiated thyroid …
bexarotene on the efficacy of radioiodine therapy for metastases of differentiated thyroid …
Struma maligna–Schilddrüsenkarzinome
C Reiners, M Dietlein, M Luster - DMW-Deutsche Medizinische …, 2008 - thieme-connect.com
Im Schilddrüsen-Sonogramm zeigte sich eine mäßig vergrößerte Schilddrüse mit
weitgehend echonormalem Reflexmuster. Das Gesamtvolumen betrug 41 ml (rechts 24 ml; …
weitgehend echonormalem Reflexmuster. Das Gesamtvolumen betrug 41 ml (rechts 24 ml; …
Transportador de yodo (NIS) y su aplicación diagnóstica y terapéutica en diferentes enfermedades
G Riesco-Eizaguirre, P Santisteban - 2008 - digital.csic.es
Durante más de 60 años, la capacidad única de la glándula tiroidea de transportar y
acumular yodo ha sido la base del diagnóstico y el tratamiento con yodo radiactivo del …
acumular yodo ha sido la base del diagnóstico y el tratamiento con yodo radiactivo del …
Evidence of Acute Pancreatitis in a Patient with Radioresistant-Differentiated Thyroid Cance
AN Elias, P Lizotte, H Hofflich - Journal of the National Medical Association, 2008 - Elsevier
Peroxisome proliferator-activated receptor (PPAR) agonists are sometimes used in patients
with radioiodine-resistant differentiated thyroid cancers in order to effect further …
with radioiodine-resistant differentiated thyroid cancers in order to effect further …